[1] |
Uusitalo E, Leppävirta J, Koffert A, et al. Incidence and mortality of neurofibromatosis: a total population study in Finland[J]. J Invest Dermatol, 2015, 135(3):904-906.
|
[2] |
Ferner RE, Bakker A, Elgersma Y, et al. From process to progress-2017 international conference on neurofibromatosis 1, neurofibromatosis 2 and schwannomatosis[J]. Am J Med Genet A, 2019, 179(6):1098-1106.
|
[3] |
Gutmann DH, Wood DL, Collins FS. Identification of the neurofibromatosis type 1 gene product[J]. Proc Natl Acad Sci USA,1991, 88(21):9658-9662.
|
[4] |
王智超,李青峰.Ⅰ型神经纤维瘤病临床诊疗专家共识(2021版)[J].中国修复重建外科杂志,2021,35(11):1384-1395.
|
[5] |
Chaudhry US, Yang L, Askeland RW, et al. Metaplastic breast cancer in a patient with neurofibromatosis[J]. J Clin Imaging Sci, 2015, 5:17.
|
[6] |
Suarez-Kelly LP, Yu L, Kline D, et al. Increased breast cancer risk in women with neurofibromatosis type 1: a meta-analysis and systematic review of the literature[J]. Hered Cancer Clin Pract, 2019, 17:12.
|
[7] |
Brasfield RD, Das Gupta TK. Von Recklinghausen’s disease: a clinicopathological study[J]. Ann Surg,1972, 175(1):86-104.
|
[8] |
Ratner N, Miller SJ. A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor[J]. Nat Rev Cancer, 2015, 15(5):290-301.
|
[9] |
Wang X, Kallionpää RA, Gonzales PR, et al. Germline and somatic NF1 alterations are linked to increased HER2 expression in breast cancer[J]. Cancer Prev Res (Phila), 2018,11(10):655-664.
|
[10] |
Mantoglu B, Kamburoglu B, Zengin I, et al. Coexistence of neurofibromatosis type 1 and male breast cancer[J]. Arch Iran Med, 2021, 24(11):852-855.
|
[11] |
Stewart DR, Korf BR, Nathanson KL, et al. Care of adults with neurofibromatosis type 1: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)[J]. Genet Med, 2018, 20(7):671-682.
|
[12] |
Crook A, Kwa R, Ephraums S, et al. The psychological impact and experience of breast cancer screening in young women with an increased risk of breast cancer due to neurofibromatosis type 1[J]. Fam Cancer, 2022, 21(2):241-253.
|
[13] |
Mendes-Pereira AM, Sims D, Dexter T, et al. Genome-wide functional screen identifies a compendium of genes affecting sensitivity to tamoxifen[J]. Proc Natl Acad Sci U S A, 2012, 109(8):2730-2735.
|